Background: TRIB1, a serine-threonine kinase-like molecule, is a biomarker of chronic antibody-mediated rejection. Results: TRIB1 is highly expressed in Tregs, where its expression correlates with Foxp3, a molecule with which it interacts directly. Conclusion: TRIB1 is a novel binding partner of Foxp3 in Tregs. Significance: TRIB1 may play a crucial role in Tregs in cooperation with Foxp3.